The Evidence Base for Diabetes CareRhys Williams, W. Herman, A.-L. Kinmonth, N. J. Wareham John Wiley & Sons, 2003 M07 11 - 796 pages This volume outlines what is meant by terms such as 'evidence based practice', 'systematic review', 'efficacy', 'effectiveness'. It summarises, in a systematic fashion, the current evidence on diabetes prevention and care to enable the reader to improve their professional practice. Furthermore, it promotes a critical attitude to the assessment of evidence and engenders enthusiasm for 'lifelong learning'. It also advises clinicians on what to do when there is little available evidence. Chapters consider the evidence base for the definition and classification of diabetes, as well as prevention, identification, treatment, education in IDDM and NIDDM. The final chapters look at the practical implications of translating this evidence into practice in different environments with different health care systems and different economic levels.
|
Contents
1 | |
11 | |
43 | |
PART III EARLY DETECTION SCREENING AND CASE FINDING IN TYPE 2 DIABETES | 189 |
PART IV GESTATIONAL DIABETES | 243 |
PART V GLYCAEMIC CONTROL | 289 |
PART VI PREVENTION OF COMPLICATIONS | 353 |
PART VII TREATMENT OF ESTABLISHED COMPLICATIONS | 499 |
PART VIII DELIVERY OF CARE | 679 |
PART IX CONTINUING EDUCATION | 727 |
Index | 753 |
Other editions - View all
The Evidence Base for Diabetes Care William Herman,Ann Louise Kinmonth,Nick Wareham,Rhys Williams Limited preview - 2009 |
The Evidence Base for Diabetes Care Rhys Williams,W. Herman,A.-L. Kinmonth,N. J. Wareham No preview available - 2003 |
Common terms and phrases
amputation artery associated baseline benefits blood glucose blood pressure cardiovascular disease cholesterol Clin clinical trials controlled trial coronary heart disease criteria DCCT dependent diabetes Diab Diabetes Control diabetic complications diabetic nephropathy diabetic patients diabetic retinopathy Diabetologia diagnosis diet dietary effect epidemiological evaluation fasting glucose follow-up gestational diabetes mellitus glucose levels glycaemia glycaemic control HbA1c hyperglycaemia hypertension IDDM impaired glucose tolerance improved included increased individuals insulin resistance intake intensive therapy intervention ischemic Journal Lancet lifestyle lipid long-term lower metabolic metformin mg/dl microalbuminuria microvascular mmol/l mortality myocardial infarction neuropathy NIDDM non-diabetic obesity OGTT outcome patients with diabetes patients with type periodontal disease physical activity placebo plasma glucose population pregnancy prevalence progression prospective study randomised randomized randomized controlled trial reduction renal reported risk factors significant smoking stroke Study Group subjects treatment troglitazone type 2 diabetes UKPDS ulcers versus weight loss women
Popular passages
Page 312 - The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
Page 162 - Pan XR, Li GW, Hu YH, et al: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Page 35 - Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Page 384 - Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
Page 625 - Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
Page 441 - Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Page 185 - Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Page 601 - The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
Page 441 - Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).